MedPath
HSA Approval

APO-AMLODIPINE TABLET 10mg

SIN14160P

APO-AMLODIPINE TABLET 10mg

APO-AMLODIPINE TABLET 10mg

June 18, 2012

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc.

Active Ingredients

Amlodipine Besylate 14mg eqv to Amlodipine

10.0mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-AMLODIPINE TABLET 10mg - HSA Approval | MedPath